Department of Health, Medicine and Caring Sciences, Linköping University, Building 511, Entrance 75, Room 13.1309 Campus US, 581 83 Linköping, Sweden.
Department of Biomedical Engineering, Linköping University, Linköping, Sweden.
Eur J Prev Cardiol. 2024 Jul 23;31(9):1152-1161. doi: 10.1093/eurjpc/zwae052.
The aim was to investigate the relationship between microvascular function, cardiovascular risk profile, and subclinical atherosclerotic burden.
The study enrolled 3809 individuals, 50-65 years old, participating in the population-based observational cross-sectional Swedish CArdioPulmonary bioImage Study. Microvascular function was assessed in forearm skin using an arterial occlusion and release protocol determining peak blood oxygen saturation (OxyP). Cardiovascular risk was calculated using the updated Systematic Coronary Risk Evaluation [SCORE2; 10-year risk of fatal and non-fatal cardiovascular disease (CVD) events]. The OxyP was compared with coronary artery calcification score (CACS) and to plaques in the carotid arteries. Individuals with OxyP values in the lowest quartile (Q1; impaired microvascular function) had a mean SCORE2 of 5.8% compared with 3.8% in those with the highest values of OxyP (Q4), a relative risk increase of 53%. The risk of having a SCORE2 > 10% was five times higher for those in Q1 (odds ratio: 4.96, 95% confidence interval: 2.76-8.93) vs. Q4 when adjusting for body mass index and high-sensitivity C-reactive protein. The OxyP was lower in individuals with CACS > 0 and in those with both carotid plaques and CACS > 0, compared with individuals without subclinical atherosclerotic burdens (87.5 ± 5.6% and 86.9 ± 6.0%, vs. 88.6 ± 5.8%, P < 0.01).
In a population without CVD or diabetes mellitus, impaired microvascular function is associated with cardiovascular risk profiles such as higher SCORE2 risk and CACS. We suggest that OxyP may serve as a microcirculatory functional marker of subclinical atherosclerosis and CVD risk that is not detected by structural assessments.
本研究旨在探讨微血管功能、心血管风险状况与亚临床动脉粥样硬化负担之间的关系。
本研究纳入了 3809 名年龄在 50-65 岁之间的个体,他们参加了基于人群的观察性横断面瑞典心肺生物影像研究。通过动脉闭塞和释放方案评估前臂皮肤的微血管功能,该方案确定峰值血氧饱和度(OxyP)。使用更新的系统性冠状动脉风险评估[SCORE2;致命和非致命心血管疾病(CVD)事件的 10 年风险]计算心血管风险。将 OxyP 与冠状动脉钙化评分(CACS)和颈动脉斑块进行比较。OxyP 值处于最低四分位数(Q1;微血管功能受损)的个体的平均 SCORE2 为 5.8%,而 OxyP 值最高的四分位数(Q4)的个体为 3.8%,相对风险增加了 53%。当调整体重指数和高敏 C 反应蛋白时,Q1 组(比值比:4.96,95%置信区间:2.76-8.93)SCORE2>10%的风险是 Q4 组的五倍。与无亚临床动脉粥样硬化负担的个体相比(87.5±5.6%和 86.9±6.0%,vs. 88.6±5.8%,P<0.01),CACS>0 以及同时存在颈动脉斑块和 CACS>0 的个体的 OxyP 值较低。
在没有 CVD 或糖尿病的人群中,微血管功能受损与心血管风险状况相关,例如更高的 SCORE2 风险和 CACS。我们认为,OxyP 可以作为亚临床动脉粥样硬化和 CVD 风险的微循环功能标志物,而这些标志物不能通过结构评估检测到。